About Sovereign Pharma Private Limited
Data last updated:
Sovereign Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 May 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24232MH2003PTC427275. Its GSTIN is 26AAHCS6304H1ZE (Daman & Diu). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹98 Cr and a paid-up capital of ₹98 Cr. It is led by directors including Kairus Shavak Dadachanji (Managing Director) and Piyush Vinodrai Desai (Whole-Time Director).
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹142.09 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹17.6 Cr (net margin 12.4%) and EBITDA of ₹32.21 Cr (EBITDA margin 22.7%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 8% over five years.
The company has about 638 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sovereign Pharma. As per MCA filings, the company has open charges of ₹15.85 Cr and satisfied charges of ₹4.22 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 1 filed against it; 2 cases are pending. The company has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹80 Cr; the latest was in March 2024. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Goodway Chemicals Private Limited with revenue of ₹144.1 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 6 overdue payments to 2 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sovereignpharma.net.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address72 – 73 7th Floor Plot 215 Free Press House, Free Press Journal Marg, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sovereign Pharma Private Limited
The main business activity of Sovereign Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sovereign Pharma Private Limited FY 2025 filings available
Sovereign Pharma Private Limited reported revenue of ₹142.09 Cr (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Sovereign Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 15% growth in the latest year. EBITDA rose 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sovereign Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹32.21 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹17.6 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sovereign Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 12.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sovereign Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Sovereign Pharma Private Limited
Sovereign Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Goodway Chemicals Private Limited | ₹144.1 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Mumbai, Maharashtra, India |
| Afrinext Overseas Private Limited | ₹144.02 Cr (FY 2025) | •••• | •••• | 65.0% | •••• | Vadodara, Gujarat, India |
| Immacule Lifesciences Private Limited | ₹143.18 Cr (FY 2025) | •••• | •••• | 34.0% | •••• | Nalagarh, Himachal Pradesh, India |
| Alventa Pharma Limited | ₹142.72 Cr (FY 2025) | •••• | •••• | 82.0% | •••• | Kolkata, West Bengal, India |
| Apotex Pharmachem India Private Limited | ₹142.14 Cr (FY 2024) | •••• | •••• | -19.0% | •••• | Bangalore, Karnataka, India |
| Sovereign Pharma Private Limited this company | ₹142.09 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Mumbai, Maharashtra, India |
| Svizera Labs Private Limited | ₹142.05 Cr (FY 2022) | •••• | •••• | 7.0% | •••• | Thane, Maharashtra, India |
| Ratnatris Pharmaceuticals Private Limited | ₹141.71 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Ahmedabad, Gujarat, India |
| Lyka Labs Limited Listed | ₹140.73 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Ankleshwar, Gujarat, India |
| Ubik Solutions Private Limited | ₹140.2 Cr (FY 2025) | •••• | •••• | •••• | Rajkot, Gujarat, India | |
| Aglowmed Limited | ₹139.55 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Patna, Bihar, India |
Peers are the five companies nearest above and the five nearest below Sovereign Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Sovereign Pharma Private Limited
Sovereign Pharma Private Limited is audited by SUDIT K PAREKH & CO. LLP for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SUDIT K PAREKH & CO. LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Sovereign Pharma Private Limited
Sovereign Pharma has 8 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kairus Shavak Dadachanji Also directs: Kairish Shared Services LLP, Kairish Real Estate LLP, Kaisha Packaging Private Limited and 4 more | Managing Director | 28 May 2003 | 23 Years 4 Months | Current |
| Cyrus Soli Poonawalla Also directs: Genesis Parks LLP, Adar Estates LLP, Poonawalla Estates Stud and Agri Farm Privae Limited and 4 more | Director | 28 May 2003 | 23 Years 4 Months | Current |
| Shapoorji Pallonji Mistry | Director | 28 May 2003 | 23 Years 4 Months | Current |
| Piyush Vinodrai Desai | Whole-Time Director | 01 Dec 2021 | 4 Years 10 Months | Current |
| Satish Hanumant Deshpande | Director | 28 May 2003 | 23 Years 4 Months | Current |
| Rishad Kairus Dadachanji Also directs: Kairish Shared Services LLP, Kairish Real Estate LLP, Kaisha Packaging Private Limited and 5 more | Director | 01 Oct 2021 | 5 Years 0 Months | Current |
Ownership and Shareholding of Sovereign Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sovereign Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2023 | Hdfc Bank Limited | ₹17.85 Lakh | Open |
| 02 Nov 2022 | Axis Bank Limited | ₹3.67 Cr | Open |
| 08 Mar 2004 | Axis Bank Limited | ₹12 Cr | Open |
| 08 Nov 2016 | Others | ₹11.19 Lakh | Satisfied |
| 26 Apr 2016 | Others | ₹18.68 Lakh | Satisfied |
Total charge records: 15 View all charges
Deals & Funding of Sovereign Pharma Private Limited
Sovereign Pharma Private Limited has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹80 Cr; the latest was in March 2024.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Funding round | ₹65 Cr | Investors: Serum Institute of India Private Limited , S P Finance Private Limited , an individual |
| May 2019 | Secondary share transfer | Undisclosed | Buyer: Serum Institute of India Private Limited , Chakan Investment Private Limited , Adurjee Bros Private Limited Seller: Poonawalla Finance Private Limited |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: Poonawalla Finance Private Limited Seller: Poonawalla Investments and Industries Private Limited |
| Aug 2011 | Funding round | ₹9 Cr | Investors: Poonawalla Investments and Industries Private Limited , S P Finance Private Limited , Poonawalla Finance Private Limited |
| Jan 2009 | Funding round | ₹4 Cr | Investors: Poonawalla Finance Private Limited , S P Finance Private Limited , an individual |
Full deal history
All 6 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Sovereign Pharma Private Limited
Sovereign Pharma Private Limited has 3 court cases on record: 1 filed by Sovereign Pharma, 1 filed against it, 1 where it is another party. 2 cases are pending and 1 is disposed. Status as checked between 01 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 2 |
| High courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Daman, The Dadra And Nagar Haveli And Daman And Diu | Court case (CP-CMA-RJE) | Company is another party | Pending |
| District court, Daman, The Dadra And Nagar Haveli And Daman And Diu | Criminal miscellaneous application | Filed by the company against State | Pending |
| Bombay High Court | Tax appeal | Filed against the company by PR. Comm. of Income Tax Central-3 Pune | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Sovereign Pharma Private Limited
Sovereign Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 6 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Earth Constructions | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Sovereign Pharma Private Limited
Sovereign Pharma operates one associated brand: Sovereign Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of injectables and diluents is conducted by Sovereign Pharma in the pharmaceutical sector. | sovereignpharma.net |
Employees and EPFO Compliance at Sovereign Pharma Private Limited
Sovereign Pharma Private Limited has a workforce of 638 employees as of Mar 26, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Sovereign Pharma Private Limited
Sovereign Pharma has one previous CIN (Corporate Identification Number): U24232PN2003PTC017981. The current CIN is U24232MH2003PTC427275, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232MH2003PTC427275 | Current |
| U24232PN2003PTC017981 | Previous |
Recent Activity on Sovereign Pharma Private Limited
Sovereign Pharma Private Limited has 13 board changes on record since 2003: 8 appointments and 5 cessations. The latest: Rishad Kairus Dadachanji ceased to be Whole-Time Director on 01 Oct 2022.
38 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Sovereign Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sovereign Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sovereign Pharma Private Limited
Sovereign Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 26AAHCS6304H1ZE | Daman & Diu | Active | 01 Aug 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sovereign Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sovereign Pharma Private Limited
Sovereign Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 May 2003 (23+ years old) and is registered under CIN U24232MH2003PTC427275.
Sovereign Pharma reported revenue of ₹142.09 Cr for FY 2025 (up 15% YoY).
Sovereign Pharma has 8 current directors:
- Kairus Shavak Dadachanji - Managing Director
- Piyush Vinodrai Desai - Whole-Time Director
- Cyrus Soli Poonawalla - Director
- Shapoorji Pallonji Mistry - Director
- Satish Hanumant Deshpande - Director
- Rishad Kairus Dadachanji - Director
- Adar Cyrus Poonawalla - Director
- Makarand Shrikrishna Karkare - Director
Sovereign Pharma reported a net profit of ₹17.6 Cr (net margin 12.4%) and EBITDA of ₹32.21 Cr (EBITDA margin 22.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sovereign Pharma is 7% over three years and 8% over five years. In the latest year (FY 2025) revenue rose 15%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sovereign Pharma is 26AAHCS6304H1ZE, registered in Daman & Diu. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Sovereign Pharma is U24232MH2003PTC427275. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sovereign Pharma has 3 court cases on record: 1 filed by the company and 1 filed against it. 2 are pending. Most are in the district courts.
Sovereign Pharma was incorporated on 28 May 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.
Sovereign Pharma has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹80 Cr; the latest was in March 2024.
The peers of Sovereign Pharma by revenue are Goodway Chemicals Private Limited, Afrinext Overseas Private Limited, Immacule Lifesciences Private Limited, Alventa Pharma Limited, Apotex Pharmachem India Private Limited and 5 more, all in the Pharma industry (Formulations).
Rishad Kairus Dadachanji ceased to be Whole-Time Director on 01 Oct 2022. Makarand Shrikrishna Karkare ceased to be Additional Director on 30 Sep 2022. Makarand Shrikrishna Karkare was appointed as Director on 01 Dec 2021. Sovereign Pharma has 13 board changes on record in total.